Ara
Toplam kayıt 3, listelenen: 1-3
Anti-interleukin-6 (tocilizumab) therapy in Takayasu’s arteritis: a real life experience
(TÜBİTAK, 2020-02-13)
Background/aim: Tumour necrosis factor inhibitors and anti-interleukin-6 (anti-IL-6) therapies are increasingly being used in Takayasu’s arteritis (TA) patients who are unresponsive to corticosteroids ± conventional ...
Geoepidemiology and clinical characteristics of neonatal lupus erythematosus: a systematic literature review of individual patients’ data
(TÜBİTAK, 2020-01-09)
Background/aim: Neonatal lupus erythematosus (NLE) is an autoimmune syndrome caused by transplacental transmission of maternal autoantibodies, often with devastating consequences. The objective of this systematic literature ...
Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid
(TÜBİTAK, 2020-02-13)
Background/aim: Avascular necrosis (AVN) is the death of bone due to compromise of blood flow. The etiology of AVN is multifactorial; corticosteroid usage is the second most significant factor after trauma, and systemic ...